Skip to main content

Advanced Search

Haematologica
  • Home
  • Current Issue
  • Ahead Of Print
  • Archive
  • Submit a Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Submit a Manuscript
    • Track a Manuscript
  • About Us
    • About Haematologica
    • Editorial Board
    • Our Policies
  • More
    • Advertising
    • Rights & Permissions
    • Alerts
    • Feedback
    • Contact
Hydroxyurea to lower TCD velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort
Robert O. Opoka, Heather A. Hume, Teresa S. Latham, Adam Lane, Olatundun Williams, Jennifer Tymon, Maria Nakafeero, Phillip Kasirye, Christopher M. Ndugwa, Chandy C. John, Russell E Ware
Haematologica October 2019 : haematol.2019.231407; doi:10.3324/haematol.2019.231407
Robert O. Opoka
Department of Paediatrics and Child Health, Makerere University, Kampala Uganda;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather A. Hume
Makerere University, Kampala Uganda and Université de Montréal, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teresa S. Latham
Department of Pediatrics, Cincinnati Children Hospital Medical Center, Cincinnati, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adam Lane
Department of Pediatrics, Cincinnati Children Hospital Medical Center, Cincinnati, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olatundun Williams
Ann and Robert H. Lurie Children Hospital of Chicago, Chicago, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jennifer Tymon
St. Luke University Health Network, Bethlehem, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Nakafeero
Department of Pediatrics, Cincinnati Children Hospital Medical Center, Cincinnati, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Phillip Kasirye
Department of Paediatrics and Child Health, Makerere University, Kampala Uganda;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher M. Ndugwa
Department of Paediatrics and Child Health, Makerere University, Kampala Uganda;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chandy C. John
Ryan White Center for Infectious Diseases and Global Health, Indianapolis, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Russell E Ware
Global Health Center, Cincinnati Children Hospital Medical Center, Cincinnati, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site

Author Affiliations

  1. Robert O. Opoka1,
  2. Heather A. Hume2,
  3. Teresa S. Latham3,
  4. Adam Lane3,
  5. Olatundun Williams4,
  6. Jennifer Tymon5,
  7. Maria Nakafeero3,
  8. Phillip Kasirye1,
  9. Christopher M. Ndugwa1,
  10. Chandy C. John6 and
  11. Russell E Ware7,*
  1. 1 Department of Paediatrics and Child Health, Makerere University, Kampala Uganda;
  2. 2 Makerere University, Kampala Uganda and Université de Montréal, Canada;
  3. 3 Department of Pediatrics, Cincinnati Children Hospital Medical Center, Cincinnati, USA;
  4. 4 Ann and Robert H. Lurie Children Hospital of Chicago, Chicago, USA;
  5. 5 St. Luke University Health Network, Bethlehem, USA;
  6. 6 Ryan White Center for Infectious Diseases and Global Health, Indianapolis, USA;
  7. 7 Global Health Center, Cincinnati Children Hospital Medical Center, Cincinnati, USA
  1. ↵* Corresponding author; email: russell.ware{at}cchmc.org
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

*_*

  • Received July 5, 2019.
  • Accepted October 24, 2019.
  • Copyright © 2019, Ferrata Storti Foundation
PreviousNext
Back to top

Keywords

Hemoglobinopathies
Hydroxyurea
sickle cell anemia
Stroke
Transcranial Doppler

Vol 104 Issue 12

Haematologica: 104 (12)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word about Haematologica.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Hydroxyurea to lower TCD velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort
(Your Name) has forwarded a page to you from Haematologica
(Your Name) thought you would like to see this page from the Haematologica web site.
Citation Tools
Hydroxyurea to lower TCD velocities and prevent primary stroke: the Uganda NOHARM sickle cell anemia cohort
Robert O. Opoka, Heather A. Hume, Teresa S. Latham, Adam Lane, Olatundun Williams, Jennifer Tymon, Maria Nakafeero, Phillip Kasirye, Christopher M. Ndugwa, Chandy C. John, Russell E Ware
Haematologica Oct 2019, haematol.2019.231407; DOI: 10.3324/haematol.2019.231407

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Robert O. Opoka, Heather A. Hume, Teresa S. Latham, Adam Lane, Olatundun Williams, Jennifer Tymon, Maria Nakafeero, Phillip Kasirye, Christopher M. Ndugwa, Chandy C. John, Russell E Ware
Haematologica Oct 2019, haematol.2019.231407; DOI: 10.3324/haematol.2019.231407
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Request Permissions
  • Tweet Widget
  • Facebook Like
  • Alert me when this article is cited
  • Alert me if a correction is posted

Jump To

  • Article
  • Info & Metrics
  • PDF

More in this TOC Section

Letter to the Editor

  • LJ000328, a novel ALK2/3 kinase inhibitor, represses hepcidin and significantly improves the phenotype of IRIDA
  • High frequency of chronic lymphocytic leukemia-like low-count monoclonal B-cell lymphocytosis in Japanese descendants living in Brazil
  • Cloning and characterization of a novel druggable fusion kinase in acute myeloid leukemia
Show more Letter to the Editor

Red Cell Biology & its Disorders

  • Disruption of the MBD2-NuRD complex but not MBD3-NuRD induces high level HbF expression in human adult erythroid cells
  • Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient
  • Comparing the two leading erythroid lines BEL-A and HUDEP-2
Show more Red Cell Biology & its Disorders

Related Articles

Cited By...

What about you?
Tell us your interests and get all the new contents of Haematologica in advance

 

 

Navigate

  • Home
  • Current issue
  • Ahead of print
  • Archive
  • Info for
    • Authors
    • Reviewers
    • Advertisers
    • Subscribers
  • About us
    • About Haematologica
    • Editorial Board
    • Our policies

For Authors

  • Author guidelines
  • Submit Manuscript
  • Track Manuscript

For Reviewers

  • Reviewer Guidelines
  • Access Your Profile
  • Access Your Tasks
  • 2014 reviewers

For Advertisers

  • Information For Advertising

Education

  • Review Articles
  • Guideline Articles

More

  • Rights & Permissions
  • Advertising
  • Alerts
  • Feedback
  • Contact
  • App

Copyright © 2019 by the Ferrata Storti Foundation

ISSN 0390-6078 print

ISSN 1592-8721 online